Oyster Point Pharma, Inc. Operating Expenses
Oyster Point Pharma, Inc. reported Operating Expenses of $38.16 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-11-10
- Oyster Point Pharma, Inc. operating expenses for the quarter ending 2022-09-30 was $38.16M, a 9.92% increase year-over-year.
- Oyster Point Pharma, Inc. operating expenses for the quarter ending 2022-06-30 was $46.77M, a 112.34% increase year-over-year.
- Oyster Point Pharma, Inc. operating expenses for the quarter ending 2022-03-31 was $44.58M, a 135.62% increase year-over-year.
- Oyster Point Pharma, Inc. operating expenses for the quarter ending 2021-12-31 was $44.01M, a 97.86% increase year-over-year.
- Oyster Point Pharma, Inc. operating expenses for fiscal 2021 was $119.67M, a 68.57% increase from fiscal 2020.
- Oyster Point Pharma, Inc. operating expenses for fiscal 2020 was $70.99M, a 50.08% increase from fiscal 2019.
- Oyster Point Pharma, Inc. operating expenses for fiscal 2019 was $47.30M, a 182.63% increase from fiscal 2018.
- Oyster Point Pharma, Inc. operating expenses for fiscal 2018 was $16.74M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2022-09-30 | $38.16M 10-Q · filed 2022-11-10 | $84.93M derived: sum of 2 quarters · filed 2022-11-10 | $129.51M 10-Q · filed 2022-11-10 | $173.52M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $46.77M 10-Q · filed 2022-08-11 | $91.35M 10-Q · filed 2022-08-11 | $135.36M derived: sum of 3 quarters · filed 2022-08-11 | $170.07M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-03-31 | $44.58M 10-Q · filed 2022-05-05 | $88.59M derived: sum of 2 quarters · filed 2022-05-05 | $123.30M derived: sum of 3 quarters · filed 2022-11-10 | $145.33M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-12-31 | $44.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $78.72M derived: sum of 2 quarters · filed 2022-11-10 | $100.75M derived: sum of 3 quarters · filed 2022-11-10 | $119.67M 10-K · filed 2022-02-24 |
| 2021-09-30 | $34.71M 10-Q · filed 2022-11-10 | $56.74M derived: sum of 2 quarters · filed 2022-11-10 | $75.66M 10-Q · filed 2022-11-10 | $97.90M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $22.03M 10-Q · filed 2022-08-11 | $40.95M 10-Q · filed 2022-08-11 | $63.19M derived: sum of 3 quarters · filed 2022-08-11 | $79.51M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $18.92M 10-Q · filed 2022-05-05 | $41.16M derived: sum of 2 quarters · filed 2022-05-05 | $57.49M derived: sum of 3 quarters · filed 2022-05-05 | $72.98M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $22.24M 10-K · filed 2021-02-18 | $38.57M derived: sum of 2 quarters · filed 2021-11-04 | $54.06M derived: sum of 3 quarters · filed 2021-11-04 | $70.99M 10-K · filed 2022-02-24 |
| 2020-09-30 | $16.32M 10-Q · filed 2021-11-04 | $31.82M derived: sum of 2 quarters · filed 2021-11-04 | $48.74M 10-Q · filed 2021-11-04 | $68.91M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $15.49M 10-Q · filed 2021-08-05 | $32.42M 10-Q · filed 2021-08-05 | $52.58M derived: sum of 3 quarters · filed 2021-08-05 | $64.48M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $16.93M 10-Q · filed 2021-05-06 | $37.09M derived: sum of 2 quarters · filed 2021-05-06 | $48.99M derived: sum of 3 quarters · filed 2021-05-06 | $60.22M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $20.16M 10-K · filed 2021-02-18 | $32.06M derived: sum of 2 quarters · filed 2021-02-18 | $43.29M derived: sum of 3 quarters · filed 2021-02-18 | $47.30M 10-K · filed 2021-02-18 |
| 2019-09-30 | $11.90M 10-K · filed 2021-02-18 | $23.13M derived: sum of 2 quarters · filed 2021-02-18 | $27.14M 10-Q · filed 2020-11-05 | $31.19M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $11.23M 10-K · filed 2021-02-18 | $15.24M 10-Q · filed 2020-08-05 | $19.29M derived: sum of 3 quarters · filed 2021-02-18 | $25.98M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $4.01M 10-K · filed 2021-02-18 | $8.06M derived: sum of 2 quarters · filed 2021-02-18 | $14.75M derived: sum of 3 quarters · filed 2021-02-18 | $17.75M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $4.05M 10-K · filed 2020-02-27 | $10.74M derived: sum of 2 quarters · filed 2020-02-27 | $13.74M derived: sum of 3 quarters · filed 2020-02-27 | $16.74M 10-K · filed 2020-02-27 |
| 2018-09-30 | $6.69M 10-K · filed 2020-02-27 | $9.69M derived: sum of 2 quarters · filed 2020-02-27 | $12.69M 10-Q · filed 2019-12-03 | |
| 2018-06-30 | $3.00M 10-K · filed 2020-02-27 | $6.00M derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $3.00M 10-K · filed 2020-02-27 |